LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Sysmex Introduces Automated Urinalysis Testing Solutions that Revolutionize Workflow at Medlab Middle East 2023

By LabMedica International staff writers
Posted on 07 Feb 2023
Image: The UN-Series can automate a lab’s urinalysis work area according to workflow preferences (Photo courtesy of Sysmex)
Image: The UN-Series can automate a lab’s urinalysis work area according to workflow preferences (Photo courtesy of Sysmex)

Sysmex Corporation (Kobe, Japan) is presenting its broad range of medical diagnostics products and solutions in the fields of hematology, urinalysis, haemostasis and flow cytometry at Medlab Middle East 2023.

At Medlab Middle East 2023, taking place 6-9 February in Dubai, Sysmex is showcasing the BloodScience Workcell which smartly combines hematology and haemostasis testing in one interdisciplinary solution – to support physicians in obtaining a more holistic picture of their patients and to improve the workflow in the laboratory. Sysmex’s novel laboratory automation concept consolidates the workflow automation of EDTA and citrate blood sample tubes by combining haematology’s XN-9100 with the new CN track for haemostasis. Both automation lines are physically connected through the tube sorter TS-10 while the capabilities of the Extended IPU facilitate a standardized work area management for hematology and haemostasis. One user can operate this automation platform that harmonizes high workload capacities for citrate and EDTA blood specimens. A safe and completely closed tube system with cap piercing functionality, it effectively reduces the biohazard risk.

Sysmex is also highlighting its modular, integrated clinical flow cytometry system that helps labs efficiently manage sample and data flow, covering the steps from sample preparation through to analysis and reporting. For instance, the programmable PS-10 from Sysmex automates sample preparation steps to match SOPs, adding increased efficiency and standardization for complex and routine flow cytometry applications. The Hettich Rotolavit II-S cell wash centrifuge automatically carries out the routine washing steps when preparing samples for flow cytometry while the award-winning Silent Design of the XN-Series set the standard for the development of this 10-colour flow cytometer for highest-level clinical requirements.

Sysmex is also presenting its urinalysis solutions that can support the diagnosis of common diseases such as urinary tract infections, kidney diseases and others. This includes the UN-Series that can automate the lab’s urinalysis work area according to workflow preferences. With modular components to mix and match, labs can tailor a complete solution that is scalable to their current and future needs, providing a perfect fit while securing your investment. While the UN-Series can cover the complete urinalysis workflow it offers labs maximum flexibility in setting up their desired workflow. Because of its modularity, labs can configure their solution to cover only the parts they require. Whatever the selection, there will be no more hands-on urinalysis as the whole process is automated, and labs get all the results on one screen, with all data centralized in one workstation.

Related Links:
Sysmex Corporation

Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Alcohol Testing Device
Dräger Alcotest 7000
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more